Abstract
Insomnia is one of the most common clinical problems being faced by people all over the world. It adversely affects the routine life of these patients giving rise to even other health issues like hypertension, diabetes, obesity, depression, heart attack, and stroke. Orexin receptor-1 (OX1R), a noteworthy drug target, when inhibited can promote sleepiness in people suffering from such conditions. OX1R is a G-protein coupled receptor which is conserved throughout the mammalian species and is located primarily in hypothalamus and locus coeruleus. The present study aims at identifying potent natural-origin inhibitors of OX1R capable of affecting the arousal and sleep pattern. In the present work, we have screened a large dataset of natural compounds against OX1R using high throughput screening and high precision docking approaches. Molecular dynamics simulations were carried out to study the dynamical behavior of the top scoring compound. We also provided mechanistic insights into the binding mode of action of this compound. The study provides evidence for consideration of this natural molecule as prospective lead in treatment of insomnia.
Keywords: Docking, insomnia, molecular dynamics simulation, natural compound, orexins, receptor.
Combinatorial Chemistry & High Throughput Screening
Title:Mechanistic Insights into Mode of Action of a Potent Natural Antagonist of Orexin Receptor-1 by Means of High Throughput Screening and Molecular Dynamics Simulations
Volume: 17 Issue: 2
Author(s): Jaspreet Kaur Dhanjal, Sonam Grover, Prateek Paruthi, Sudhanshu Sharma and Abhinav Grover
Affiliation:
Keywords: Docking, insomnia, molecular dynamics simulation, natural compound, orexins, receptor.
Abstract: Insomnia is one of the most common clinical problems being faced by people all over the world. It adversely affects the routine life of these patients giving rise to even other health issues like hypertension, diabetes, obesity, depression, heart attack, and stroke. Orexin receptor-1 (OX1R), a noteworthy drug target, when inhibited can promote sleepiness in people suffering from such conditions. OX1R is a G-protein coupled receptor which is conserved throughout the mammalian species and is located primarily in hypothalamus and locus coeruleus. The present study aims at identifying potent natural-origin inhibitors of OX1R capable of affecting the arousal and sleep pattern. In the present work, we have screened a large dataset of natural compounds against OX1R using high throughput screening and high precision docking approaches. Molecular dynamics simulations were carried out to study the dynamical behavior of the top scoring compound. We also provided mechanistic insights into the binding mode of action of this compound. The study provides evidence for consideration of this natural molecule as prospective lead in treatment of insomnia.
Export Options
About this article
Cite this article as:
Dhanjal Kaur Jaspreet, Grover Sonam, Paruthi Prateek, Sharma Sudhanshu and Grover Abhinav, Mechanistic Insights into Mode of Action of a Potent Natural Antagonist of Orexin Receptor-1 by Means of High Throughput Screening and Molecular Dynamics Simulations, Combinatorial Chemistry & High Throughput Screening 2014; 17 (2) . https://dx.doi.org/10.2174/13862073113166660061
DOI https://dx.doi.org/10.2174/13862073113166660061 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy as a Novel Pharmaceutical Intervention for Stroke
Current Pharmaceutical Design Effect of Colestimide on Reduction of Body Weight and Waist Circumference in Metabolic Syndrome Patients with Cardiovascular Risk Factors
Vascular Disease Prevention (Discontinued) Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets How to Review the Medication History to Find the Next Best Drug: The “Pretreatment-Next Treatment Algorithm and Checklist”
Current Psychopharmacology The Relationship between Age-Related Kidney Dysfunction and Framingham Risk Score in Healthy People in China
Current Aging Science Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Can Statins Prevent Progression of Degenerated Aortic Valve Stenosis?
Vascular Disease Prevention (Discontinued) Radial Approach for Percutaneous Coronary Intervention
Reviews on Recent Clinical Trials Risk Factors for Development of Heart Failure
Current Cardiology Reviews Activation of the Renin-angiotensin System could Cause Hypertension During Fasting in Muslims in the Month of Ramadhan
Current Hypertension Reviews Heat Shock Protein Inhibitors for the Treatment of Fungal Infections
Recent Patents on Anti-Infective Drug Discovery Renin-Angiotensin System in Diabetes
Protein & Peptide Letters Editorial: Oxidative Stress in Pathophysiological Conditions
Current Vascular Pharmacology Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders New Developments on Thromboxane and Prostacyclin Modulators Part II: Prostacyclin Modulators
Current Medicinal Chemistry A Neurotrophic Rationale for the Therapy of Neurodegenerative Disorders
Current Alzheimer Research Computational Studies of 1-Hydrazinophthalazine (Hydralazine) as Antineoplasic Agent. Docking Studies on Methyltransferase
Letters in Drug Design & Discovery Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling
Current Medicinal Chemistry Heart Failure Pharmacotherapy and Supports in the Elderly - A Short Review
Current Cardiology Reviews Impact of Computational Structure-based Methods on Drug Discovery
Current Pharmaceutical Design